Physician gender and changes in drug prescribing after the implementation of reference pricing in British Columbia

Clinical Therapeutics

Volumn 25, Issue 1, 2003, Pages 273-284

  Duetz, Margreet S ^a,b   Schneeweiss, Sebastian ^a,c   Maclure, Malcolm ^c,d   Abel, Thomas ^b   Glynn, Robert J ^a,b,c   Soumerai, Stephen B ^e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF VICTORIA   (Canada)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Angiotensin converting enzyme inhibitors; Claims data; Cost sharing; Drug benefits policy; Pharmacoeconomics; Pharmacoepidemiology; Physician gender

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CANADA; CHRONIC DISEASE; CLINICAL PRACTICE; COST CONTROL; FEMALE; GENDER; GENERAL PRACTITIONER; HEALTH CARE POLICY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICIAN ATTITUDE; PRESCRIPTION;

EID: 0037279828     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(03)90037-3     Document Type: Article

References (29)

1. Huskamp HA, Rosenthal MB, Frank RG, Newhouse JP. The Medicare prescription drug benefit: How will the game be played? Health Aff (Millwood). 2000;19:8-23.
2. Schneeweiss S, Walker A, Glynn RJ, et al. Outcomes of reference pricing for angiotensin-converting enzyme inhibitors. N Engl J Med. 2002;346:822-829.
3. Schneeweiss S, Soumerai SB, Glynn R, et al. Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization. CMAJ. 2002;166:737-748.
4. Matthews S, Hertzman C, Ostry A, Power C. Gender, work roles and psychosocial work characteristics as determinants of health. Soc Sci Med. 1998;46:1417-1424.
5. Matthews S, Manor O, Power C. Social inequalities in health: Are there gender differences? Soc Sci Med. 1999;48:49-60.
6. Safran DG, Rogers WH, Tarlov AR, et al. Gender differences in medical treatment: The case of physician-prescribed activity restrictions. Soc Sci Med. 1997;45:711-722.
7. Verbrugge LM, Wingard DL. Sex differentials in health and mortality. Women Health. 1987;12:103-145.
8. Woodward CA, Ferrier B, Williams AP, Cohen M. Current health policy initiatives and options. New-to-practice family physicians' attitudes. Can Fam Physician. 1995;41:2104-2111.
9. Levinson W. In context: Physician-patient communication and managed care. J Med Pract Manage. 1999;14:226-230.
10. Lurie N, Slater J, McGovern P, et al. Preventive care for women. Does the sex of the physician matter? N Engl J Med. 1993;329:478-482.
11. Mitler LK, Rizzo JA, Horwitz SM. Physician gender and cesarean sections. J Clin Epidemiol. 2000;53:1030-1035.
12. Stromme HK, Botten G. Factors relating to the choice of antihypertensive and hypnotic drug treatment in old patients. A study of a sample of Norwegian general practitioners. Scand J Prim Health Care. 1992;10:301-305.
13. Pharmacare. Antihypertensives: Information on reference drug pricing in British Columbia. Letter to doctors. Victoria, 1997.
14. Ensuring cost-effective drug therapies. Managing the Cost of Drug Therapies and Fostering Appropriate Drug Use. Victoria, BC: Office of the Auditor General of British Columbia; 1998.
15. Anderson GM, Kerluke KJ, Pulcins IR, et al. Trends and determinants of prescription drug expenditures in the elderly: Data from the British Columbia Pharmacare Program. Inquiry. 1993;30:199-207.
16. Williams J, Young W. Inventory of studies on the accuracy of Canadian health administrative databases. Technical report. Toronto: Institute for Clinical Evaluative Sciences (ICES); 1996. Pub no. 96-03-TR.
17. Fisher ES, Whaley FS, Krushat WM, et al. The accuracy of Medicare's hospital claims data: Progress has been made, but problems remain. Am J Public Health. 1992;82:243-248.
18. Fowles JB, Lawthers AG, Weiner JP, et al. Agreement between physicians' office records and Medicare Part B claims data. Health Care Financ Rev. 1995;16:189-199.
19. Glynn RJ, Monane M, Gurwitz JH, et al. Agreement between drug treatment data and a discharge diagnosis of diabetes mellitus in the elderly. Am J Epidemiol. 1999;149:541-549.
20. Romano PS, Mark DH. Bias in the coding of hospital discharge data and its implications for quality assessment. Med Care. 1994;32:81-90.
21. Johnson RE, Hornbrook MC, Nichols GA. Replicating the chronic disease score (CDS) from automated pharmacy data. J Clin Epidemiol. 1994;47:1191-1199.
22. Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol. 1992;45:197-203.
23. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
24. Hall JA, Palmer RH, Orav EJ, et al. Performance quality, gender, and professional role. A study of physicians and nonphysicians in 16 ambulatory care practices. Med Care. 1990;28:489-501.
25. Hall JA, Irish JT, Roter DL, et al. Satisfaction, gender, and communication in medical visits. Med Care. 1994;32:1216-1231.
26. Kaplan SH, Gandek B, Greenfield S, et al. Patient and visit characteristics related to physicians' participatory decision-making style. Results from the Medical Outcomes Study. Med Care. 1995;33:1176-1187.
27. Kaplan SH, Greenfield S, Gandek B, et al. Characteristics of physicians with participatory decision-making styles. Ann Intern Med. 1996;124:497-504.
28. Carr PL, Ash AS, Friedman RH, et al. Relation of family responsibilities and gender to the productivity and career satisfaction of medical faculty. Ann Intern Ned. 1998;129:532-538.
29. Belsley DA, Kuh E, Welsch RE, eds. Regression Diagnostics: Identifying Influential Data and Sources of Collinearity. New York: Wiley; 1980.